.png){kind=icon}
.png){kind=icon}
Return
Effectiveness of beta-blockers in COPD and CVD: Real-world effects on mortality
.png){kind=icon}
PRE
AI
S
S
C
P
DOI：10.1016/j.chest.2026.06.074.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
While beta-blockers are effective at reducing mortality in certain cardiovascular diseases (CVD), their effectiveness in patients with chronic obstructive pulmonary disease (COPD) and CVD is uncertain, particularly with the concurrent use of long-acting β2-agonist bronchodilators (LABA).
Journal
IF:
8.6
Papers:
4.9W
Citations:
5.1W
Organization
Cited Papers